Uprizing 2.0 Recalled Because Product Contains Steroid Superdrol
October 3, 2011, Marietta, Georgia. Superior Metabolic Technologies Inc of Marietta, Georgia is voluntarily recalling all lots of the testosterone booster Uprizing 2.0 because tests have shown the product appears to contain superdrol, a synthetic steroid, making it an unapproved new drug.
On August 5 the FDA made Superior Metabolic Technologies Inc aware that Uprizing 2.0 contains superdrol which is banned by the FDA. This led to the recall of the product.
Acute liver injury is known to be a possible harmful effect of using products containing synthetic anabolic steroids. In addition, use of synthetic anabolic steroids may cause other serious long-term adverse health consequences in men, women, and children. These include shrinkage of the testes and male infertility, masculinization of women, breast enlargement in males, short stature in children, a higher prediction to misuse other drugs and alcohol, adverse effects on blood lipid levels, and increased risk of heart attack, stroke, and death.
Uprizing 2.0 was distributed through retail health food stores in Alabama, Arizona, California, Georgia, Mississippi, New Jersey, South Carolina, and Texas.
Uprizing 2.0 comes in a black plastic bottle with a black, red, and silver label and contains 90 capsules. The SMT logo is center top on the bottle.
Consumers who purchased Uprizing 2.0 are urged to return it to the place of purchase for a full refund. Consumers with questions may contact the company at 1-888-445-3230, from 10 AM to 6 PM EST Monday through Friday.
Adverse reactions or quality problems experienced with the use of these products may be reported to Superior Metabolic Technologies Inc toll free at 1-888-445-3230 or to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail, or by fax.
Regular mail: Use postage-paid, pre-addressed Form FDA 3500 available at: www.fda.gov/MedWatch/getforms.htm. Mail to address on the pre-addressed form.
This voluntary recall is being conducted with the knowledge of the U.S. Food & Drug Administration.